Study Title: A Phase 0 Master Protocol Using the CIVO Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients with Solid Tumors.
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Jason Newman, at newmajas@musc.edu.Study Coordinator, Kendall Preston, at prestoke@musc.edu.Trial opened at the following institutions: Medical University of South Carolina